Showing results (371-380 of 928) with videos related to
Sort By:
Pageof 93
Therapeutic Advances in Psychopharmacology|February 26, 2016
A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorderDawn F Ionescu, Maurizio Fava, Daniel Ju Hyung Kim, et al.NPJ Digital Medicine|May 29, 2026
Effects of early life adversity on socially learned analgesia and empathy in virtual realityLakota Watson, Yang Wang, Jewel N White, et al.Pain|July 24, 2020
Placebo hypoalgesia: racial differencesChika Okusogu, Yang Wang, Titilola Akintola, et al.Frontiers in Psychiatry|July 21, 2022
Educational Intervention for Management of Acute Trauma Pain: A Proof-of-Concept Study in Post-surgical Trauma PatientsLuana Colloca, Ariana Taj, Rachel Massalee, et al.Journal of Affective Disorders|March 17, 2004
The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorderRoy H Perlis, Jordan W Smoller, Maurizio Fava, et al.Psychiatry Research|February 19, 2002
NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatientsTimothy Petersen, George I Papakostas, Kathryn Bottonari, et al.The American Journal of Psychiatry|November 26, 2003
The impact of medical comorbidity on acute treatment in major depressive disorderDan V Iosifescu, Andrew A Nierenberg, Jonathan E Alpert, et al.General Hospital Psychiatry|April 12, 2023
Ages at menarche and menopause, hormone therapy, and the risk of depressionHyewon Kim, Jin Hyung Jung, Kyungdo Han, et al.Biological Psychiatry|April 4, 2006
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorderMaurizio Fava, W Vaughn McCall, Andrew Krystal, et al.Journal of Clinical Psychopharmacology|March 23, 2002
Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomniaMaurizio Fava, Sharon L Hoog, Rajinder A Judge, et al.Pageof 93